MIAMI, Aug. 13, 2026 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT) ("NextNRG" or the "Company"), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced financial results …
SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an investigational, potentially first-in-class WEE1 inhibitor, …
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today …
$26.2 million in U.S. neffy® net product revenue in Q2 2026; total U.S. epinephrine market share for Type 1 allergies of 5% and 8% share within field-targeted accounts Commercial investment realigned toward targeted provider engagement, significantly …
BOISE, Idaho, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today launched the Micron Ventures Paradigm Fund, a $250 million investment vehicle built to partner with the companies shaping the future of AI. Micron Ventures’ third …
Record revenue $9.12 billion, up 25 percent year over year GAAP gross margin 50.3 percent and non-GAAP gross margin 50.4 percent GAAP EPS $3.17 and record non-GAAP EPS $3.50, up 43 percent and 41 percent year over year, respectively EPIC Center R&D …
$1.7 Million First-Half Revenue, Up 19% Year Over Year $1.2 Million Second-Quarter Revenue as U.S. DoW POR Deliveries Moved to a Monthly Cadence New Products Launch Followed by Design Wins and Initial Orders for MultiBand & Tactical Expanding SkyHopper …
– ONWARD3: 54% of patients reached complete skin clearance (PASI 100) at 48 weeks, positioning envudeucitinib to set a new standard in PsO – – Alumis remains on track to submit its New Drug Application to FDA for envudeucitinib in moderate-to-severe plaque …
Final Data from Phase 2 Expansion Study of NUC-7738 Remains on Track for 2026 Advancing Additional Indications and Combination Strategies for NUC-7738 Cash Runway Expected to Extend into 2029 EDINBURGH, United Kingdom, Aug. 13, 2026 (GLOBE NEWSWIRE) -- …
Presented first-in-human clinical imaging and dosimetry data for AKY-2519, supporting a broad clinical development program in patients with prostate, lung, and other B7-H3 expressing solid tumors Enrolling patients in Phase 1b trial of AKY-1189 in locally …
Following the observation of multiple complete responses, Elicio plans to initiate a Phase 1 combination study of ELI-002 7P plus a RAS small molecule inhibitor with or without an anti-PD-1 inhibitor in metastatic pancreatic cancer; Phase 1 study …
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) ("IREN") today announced that it will release its financial results for the fiscal year ended June 30, 2026, on Thursday, August 27, 2026 and host a conference call beginning …
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- As lawmakers, parents and the public debate how to respond to growing concerns about youth wellbeing, new nationwide research suggests most Americans believe the solution to youth mental health is far more …
Did you buy CCOI common stock between February 29, 2024 and May 1, 2026? Affected CCOI Investor Summary Who: Cogent Communications Holdings, Inc. (NASDAQ: CCOI) What: Securities fraud class action lawsuit filed Class Period: February 29, 2024 through May 1 …
– Expanded ABI-6250 clinical development into cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) – – Completed $115 million gross financing to support advancement of pipeline programs through …
LOS ANGELES, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming September 21, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise …
ST. PETERSBURG, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or “Company”), parent company of BayFirst National Bank (“Bank”) reported a net loss of $32.7 million, or $8.05 per common share and diluted common …
Announced positive blinded six-month interim safety and biomarker results from PRECISE-AD, the Company's Phase 1b trial of PMN310 in patients with early Alzheimer's disease (AD), including zero cases of amyloid-related imaging abnormalities-edema …
Second quarter revenue growth of 16% to $27.2 million Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, California – August 13, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a …
TROY, Mich., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Kelly Pediatric Therapy, a division of Kelly Education, today released The Hidden Workload Behind School-Based Pediatric Therapy, a new white paper based on original survey data from 255 school-based pediatric …
03 days 19:41:11
